BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25329968)

  • 21. Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.
    Keane PA; Patel PJ; Ouyang Y; Chen FK; Ikeji F; Walsh AC; Tufail A; Sadda SR
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5431-7. PubMed ID: 20554607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Visual and anatomical outcomes of three intravitreal aflibercept injections in eyes with neovascular form of age-related macular degeneration].
    Kałuiny JJ; Majer A; Jaworowska-Cieślińska I
    Klin Oczna; 2015; 117(1):9-13. PubMed ID: 26349151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological and functional analysis of the loading regimen with intravitreal ranibizumab in neovascular age-related macular degeneration.
    Bolz M; Simader C; Ritter M; Ahlers C; Benesch T; Prünte C; Schmidt-Erfurth U
    Br J Ophthalmol; 2010 Feb; 94(2):185-9. PubMed ID: 19692384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between outer retinal thickness substructures and visual acuity in eyes with dry age-related macular degeneration.
    Pappuru RR; Ouyang Y; Nittala MG; Hemmati HD; Keane PA; Walsh AC; Sadda SR
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6743-8. PubMed ID: 21685337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits of aflibercept treatment for age-related macular degeneration patients with good best-corrected visual acuity at baseline.
    Minami S; Nagai N; Suzuki M; Kurihara T; Sonobe H; Kamoshita M; Uchida A; Shinoda H; Takagi H; Sonoda S; Sakamoto T; Tsubota K; Ozawa Y
    Sci Rep; 2018 Jan; 8(1):58. PubMed ID: 29311612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bevacizumab for neovascular age-related macular degeneration in China.
    Li X; Hu Y; Sun X; Zhang J; Zhang M;
    Ophthalmology; 2012 Oct; 119(10):2087-93. PubMed ID: 22818896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term longitudinal modifications in mesopic microperimetry in early and intermediate age-related macular degeneration.
    Vujosevic S; Pucci P; Casciano M; Longhin E; Convento E; Bini S; Midena E
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):301-309. PubMed ID: 27582087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal bevacizumab for exudative age-related macular degeneration after multiple treatments.
    Aggio FB; Farah ME; Silva WC; Melo GB
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):215-20. PubMed ID: 17139490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
    Age-Related Eye Disease Study Research Group
    Arch Ophthalmol; 2001 Oct; 119(10):1417-36. PubMed ID: 11594942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
    Azar G; Quaranta-El Maftouhi M; Masella JJ; Mauget-Faÿsse M
    J Fr Ophtalmol; 2017 Apr; 40(4):303-313. PubMed ID: 28336284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary supplementation: effects on visual performance and occurrence of AMD and cataracts.
    Barker FM
    Curr Med Res Opin; 2010 Aug; 26(8):2011-23. PubMed ID: 20590393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choroid, Haller's, and Sattler's layer thickness in intermediate age-related macular degeneration with and without fellow neovascular eyes.
    Esmaeelpour M; Ansari-Shahrezaei S; Glittenberg C; Nemetz S; Kraus MF; Hornegger J; Fujimoto JG; Drexler W; Binder S
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5074-80. PubMed ID: 25052997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring retinal function in neovascular maculopathy using multifocal electroretinography - early and long-term correlation with clinical findings.
    Jurklies B; Weismann M; Hüsing J; Sutter EE; Bornfeld N
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):244-64. PubMed ID: 11981638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of retinal morphology and retinal sensitivity in the treatment of neovascular age-related macular degeneration using aflibercept.
    Sulzbacher F; Roberts P; Munk MR; Kaider A; Kroh ME; Sacu S; Schmidt-Erfurth U;
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(2):1158-67. PubMed ID: 25503456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization.
    Hee MR; Baumal CR; Puliafito CA; Duker JS; Reichel E; Wilkins JR; Coker JG; Schuman JS; Swanson EA; Fujimoto JG
    Ophthalmology; 1996 Aug; 103(8):1260-70. PubMed ID: 8764797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
    Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recovery of the neurosensory retina after macular translocation surgery is independent of preoperative macular sensitivity in neovascular age-related macular degeneration.
    Mettu PS; Sarin N; Stinnett SS; Toth CA
    Retina; 2011 Sep; 31(8):1637-49. PubMed ID: 21775925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.
    Joeres S; Kaplowitz K; Brubaker JW; Updike PG; Collins AT; Walsh AC; Romano PW; Sadda SR
    Ophthalmology; 2008 Feb; 115(2):347-354.e2. PubMed ID: 17628685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relating Retinal Morphology and Function in Aging and Early to Intermediate Age-related Macular Degeneration Subjects.
    Sevilla MB; McGwin G; Lad EM; Clark M; Yuan EL; Farsiu S; Curcio CA; Owsley C; Toth CA
    Am J Ophthalmol; 2016 May; 165():65-77. PubMed ID: 26940163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macular pigment, visual function, and macular disease among subjects with Alzheimer's disease: an exploratory study.
    Nolan JM; Loskutova E; Howard AN; Moran R; Mulcahy R; Stack J; Bolger M; Dennison J; Akuffo KO; Owens N; Thurnham DI; Beatty S
    J Alzheimers Dis; 2014; 42(4):1191-202. PubMed ID: 25024317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.